159 related articles for article (PubMed ID: 36319930)
1. Identification of small molecules as potential inhibitors of interleukin 6: a multi-computational investigation.
Tran QH; Nguyen QT; Tran TN; Tran TD; Le MT; Trinh DT; Tran VT; Tran VH; Thai KM
Mol Divers; 2023 Oct; 27(5):2315-2330. PubMed ID: 36319930
[TBL] [Abstract][Full Text] [Related]
2. Targeting Olokizumab-Interleukin 6 interaction interface to discover novel IL-6 inhibitors.
Tran QH; Cao HN; Nguyen DN; Tran TT; Le MT; Nguyen QT; Tran VT; Tran VH; Thai KM
J Biomol Struct Dyn; 2023; 41(23):14003-14015. PubMed ID: 36995131
[TBL] [Abstract][Full Text] [Related]
3. Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations.
Tran QH; Nguyen QT; Vo NQ; Mai TT; Tran TT; Tran TD; Le MT; Trinh DT; Thai KM
PLoS One; 2022; 17(4):e0266632. PubMed ID: 35385549
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential interleukin-8 inhibitors acting on the interactive site between chemokine and CXCR2 receptor: A computational approach.
Tran TT; Tran QH; Nguyen QT; Le MT; Trinh DT; Thai KM
PLoS One; 2022; 17(2):e0264385. PubMed ID: 35202450
[TBL] [Abstract][Full Text] [Related]
5. LY3041658/ interleukin-8 complex structure as targets for IL-8 small molecule inhibitors discovery using a combination of in silico methods.
Tran TTN; Tran QH; Nguyen QT; Le MT; Trinh DTT; Tran VH; Thai KM
SAR QSAR Environ Res; 2022 Oct; 33(10):753-778. PubMed ID: 36318662
[TBL] [Abstract][Full Text] [Related]
6. Structure-based discovery of interleukin-33 inhibitors: a pharmacophore modelling, molecular docking, and molecular dynamics simulation approach.
Le MT; Mai TT; Huynh PNH; Tran TD; Thai KM; Nguyen QT
SAR QSAR Environ Res; 2020 Dec; 31(12):883-904. PubMed ID: 33191795
[TBL] [Abstract][Full Text] [Related]
7. Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches.
Rehman HM; Sajjad M; Ali MA; Gul R; Naveed M; Aslam MS; Shinwari K; Bhinder MA; Ghani MU; Saleem M; Rather MA; Ahmad I; Amin A
Int J Biol Macromol; 2023 May; 237():124169. PubMed ID: 36990409
[TBL] [Abstract][Full Text] [Related]
8. Discovery of small molecular inhibitors for interleukin-33/ST2 protein-protein interaction: a virtual screening, molecular dynamics simulations and binding free energy calculations.
Mai TT; Nguyen PG; Le MT; Tran TD; Huynh PNH; Trinh DT; Nguyen QT; Thai KM
Mol Divers; 2022 Oct; 26(5):2659-2678. PubMed ID: 35031934
[TBL] [Abstract][Full Text] [Related]
9. Molecular Design of Novel Inhibitor by Targeting IL-6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold-Hopping Techniques: A Dual Therapeutic Strategy for COVID-19 and Cancer.
Paul I; Roy A; Ray S
Chem Biodivers; 2023 Dec; 20(12):e202300806. PubMed ID: 37967248
[TBL] [Abstract][Full Text] [Related]
10. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.
Shi L; Wen Z; Song Y; Wang J; Yu D
J Mol Graph Model; 2022 Dec; 117():108306. PubMed ID: 36063745
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
Mishra V; Pathak C
J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
[TBL] [Abstract][Full Text] [Related]
12. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.
El-Hasab MAE; El-Bastawissy EE; El-Moselhy TF
J Biomol Struct Dyn; 2018 May; 36(7):1713-1727. PubMed ID: 28531373
[TBL] [Abstract][Full Text] [Related]
14. Interface inhibitory action on Interleukin-1β using selected anti-inflammatory compounds to mitigate the depression: A computational investigation.
Sardar M; Zia K; Ashraf S; Malik HN; Jabeen A; Khan KM; Ul-Haq Z
Comput Biol Chem; 2022 Dec; 101():107774. PubMed ID: 36162184
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore modelling, docking and molecular dynamic simulation studies in the discovery of potential human renin inhibitors.
Halimi M; Hajipasha A
J Mol Graph Model; 2022 Nov; 116():108272. PubMed ID: 35932508
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19.
Fayyazi N; Mostashari-Rad T; Ghasemi JB; Ardakani MM; Kobarfard F
J Biomol Struct Dyn; 2022; 40(22):11787-11808. PubMed ID: 34405765
[TBL] [Abstract][Full Text] [Related]
17. Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure-Activity Relationships and Molecular Docking.
Nada H; Sivaraman A; Lu Q; Min K; Kim S; Goo JI; Choi Y; Lee K
J Med Chem; 2023 Apr; 66(7):4417-4433. PubMed ID: 36971365
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.
Malik A; Naz A; Ahmad S; Hafeez M; Awan FM; Jafar TH; Zahid A; Ikram A; Rauff B; Hassan M
Bioinform Biol Insights; 2021; 15():11779322211021430. PubMed ID: 34163151
[TBL] [Abstract][Full Text] [Related]
19. Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation.
Sabki A; Khelifi L; Kameli A; Baali S
Chem Biodivers; 2023 Mar; 20(3):e202200933. PubMed ID: 36799050
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel inhibitors of S-adenosyl-L-homocysteine hydrolase via structure-based virtual screening and molecular dynamics simulations.
Chen C; Zhou XH; Cheng W; Peng YF; Yu QM; Tan XD
J Mol Model; 2022 Sep; 28(10):336. PubMed ID: 36180796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
